Share
March 2019 News from Champions Oncology

Covering a full range of research and development solutions that help guide decision making for clinical oncology drug development, here's where you can stay up-to-date on news, events, and special opportunities for study enrollment.

JOIN CHAMPIONS AT AACR 2019


AACR begins this week in Atlanta. Champions will be present in the exhibit hall (Booth 4652)

We are available to meet to discuss your oncology drug development needs. Please request a meeting with us here



AML VITROSCREEN -
Enrollment Ending April 30th


Available slots in our next AML In Vitro are quickly filling up. Screen either 15 or 30 Primary AML Models which have never been passaged in vivo.

Models have been characterized for

- In Vitro proliferation and AraC dose response
- Clinical and Targeted Sequencing Information

10 slots/model are available on a first-come, first-served basis

End point is either Cell Titer Glo or Flow Cytometry read out.

Find out more information here

AACR AML POSTER PRESENTATION


Champions will be presenting data on our AML Ex Vivo platform utilizing primary patient samples. Our presentation is on April 2nd at

Please reach out if you would like a copy of the presentation after the conference.


GYNECOLOGICAL PDX SCREEN
- Enrollment Ending April 30th

A few remaining spaces are available in our latest PDX indication screen across 30 Ovarian, Uterine and Endometrial models.

All models are characterized with;

- NGS data
- Patient treatment history
- In vivo drug testing.


Please contact Chris Noakes today at cnoakes@championsoncology.com
or 858-752-4544 for more information
Copyright © 2019, All rights reserved.

Our mailing address is:
Corporate Headquarters
One University Plaza
Suite 307
Hackensack, NJ 07601

Champions TumorGraft is a registered trademark of Champions Oncology

 
 

Email Marketing by ActiveCampaign